DK147851C - Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr - Google Patents

Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Info

Publication number
DK147851C
DK147851C DK225073A DK225073A DK147851C DK 147851 C DK147851 C DK 147851C DK 225073 A DK225073 A DK 225073A DK 225073 A DK225073 A DK 225073A DK 147851 C DK147851 C DK 147851C
Authority
DK
Denmark
Prior art keywords
nonapeptidamide
hypophyphenic
diagnostication
gonadotropine
deficiency
Prior art date
Application number
DK225073A
Other languages
Danish (da)
English (en)
Other versions
DK147851B (da
Inventor
Mashiko Fujino
Shigeru Kobayashi
Mikihiko Obayashi
Susumu Shinagawa
Tsunehiko Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4268672A external-priority patent/JPS5324423B2/ja
Priority claimed from JP11845272A external-priority patent/JPS5324424B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to DK441083A priority Critical patent/DK149755C/da
Publication of DK147851B publication Critical patent/DK147851B/da
Application granted granted Critical
Publication of DK147851C publication Critical patent/DK147851C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK225073A 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr DK147851C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK441083A DK149755C (da) 1972-04-29 1983-09-27 Analogifremgangsmaade til fremstilling af lhrh-analoge nonapeptidamidderivater eller fysiologisk acceptable salte eller metalkomplekser deraf

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4268672 1972-04-29
JP4268672A JPS5324423B2 (enExample) 1972-04-29 1972-04-29
JP11845272A JPS5324424B2 (enExample) 1972-11-24 1972-11-24
JP11845272 1972-11-24

Publications (2)

Publication Number Publication Date
DK147851B DK147851B (da) 1984-12-24
DK147851C true DK147851C (da) 1986-03-10

Family

ID=26382407

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225073A DK147851C (da) 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Country Status (17)

Country Link
US (1) US3853837A (enExample)
AT (1) AT333988B (enExample)
AU (1) AU453931B2 (enExample)
CA (1) CA1005815A (enExample)
CH (1) CH580065A5 (enExample)
CS (1) CS188162B2 (enExample)
DE (2) DE2321174C2 (enExample)
DK (1) DK147851C (enExample)
ES (1) ES414197A1 (enExample)
FI (1) FI56676C (enExample)
FR (1) FR2183021B1 (enExample)
GB (1) GB1403642A (enExample)
HU (1) HU168696B (enExample)
NL (2) NL176856C (enExample)
NO (1) NO139560C (enExample)
PL (1) PL95790B1 (enExample)
SE (1) SE397520B (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931138A (en) * 1973-03-13 1976-01-06 Abbott Laboratories N-carbobenzoxy-pyroglutamyl-histidine
CS180644B2 (en) * 1973-09-29 1978-01-31 Takeda Chemical Industries Ltd Process for preparing nonapeptides
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
ATE161716T1 (de) 1992-08-07 1998-01-15 Takeda Chemical Industries Ltd Herstellung von mikrokapseln, die wasserlösliche arzneimittel enthalten
ATE178789T1 (de) * 1994-02-21 1999-04-15 Takeda Chemical Industries Ltd Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CN1095681C (zh) * 1996-06-20 2002-12-11 久光制药株式会社 一种用于离子电渗疗法的装置结构
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
DK2767292T3 (en) 2004-09-17 2016-12-19 Durect Corp RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
EP2067471B1 (en) 2007-12-06 2018-02-14 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN109475505A (zh) 2016-07-06 2019-03-15 度瑞公司 具有药物组成物、屏障层及药物层的口服剂型
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Also Published As

Publication number Publication date
NO139560C (no) 1979-04-04
ATA377173A (de) 1976-04-15
NL176856C (nl) 1985-06-17
DE2321174A1 (de) 1973-11-08
FI56676C (fi) 1980-03-10
US3853837A (en) 1974-12-10
NL930004I1 (nl) 1993-04-01
ES414197A1 (es) 1976-05-01
SE397520B (sv) 1977-11-07
FR2183021A1 (enExample) 1973-12-14
DE2321174C2 (de) 1982-04-15
CA1005815A (en) 1977-02-22
PL95790B1 (pl) 1977-11-30
NO139560B (no) 1978-12-27
FI56676B (fi) 1979-11-30
GB1403642A (en) 1975-08-28
NL7305995A (enExample) 1973-10-31
DK147851B (da) 1984-12-24
AU453931B2 (en) 1974-10-17
AU5467673A (en) 1974-10-17
CS188162B2 (en) 1979-02-28
DE2366379C2 (de) 1985-01-17
HU168696B (enExample) 1976-06-28
AT333988B (de) 1976-12-27
CH580065A5 (enExample) 1976-09-30
FR2183021B1 (enExample) 1976-04-09

Similar Documents

Publication Publication Date Title
DK20979A (da) 4-amino-5-alkylsulfonyl-0-anisamid-derivater samt fremgangsmaade til fremstilling deraf
DK293575A (da) Triazolyl-alkanoner og -alkanoler samt fremgangsmade til deres fremstilling og deres anvendelse
DK93880A (da) Polyolderivater samt deres fremstilling og anvendelse
NL930029I1 (nl) Enzyme derivatives and their preparation
SE418088B (sv) Med glyoxal behandlad akrylpolymer i finfordelad form samt motsvarande framstellningsforfarande
LT2274B (lt) Benzimidazolo dariniu arba ju drusku gavimo budas
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK301477A (da) Fremgangsmaade til stereoselektiv fremstilling af hexahydrodibenzopyranoner samt mellemprodukt til brug ved fremgangsmaaden
MX150412A (es) Mejoras en taco expansible
SE7607107L (sv) Forfarande och anleggning for reglering av fetthalten i mjolk
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
AR221831A1 (es) Composicion conservadora de madera y de productos lenosos
NO149477C (no) Fremgangsmaate for fremstilling av limt papir samt limemiddel for bruk i fremgangsmaaten
CH532031A (de) Verfahren zur Herstellung von in 2-Stellung substituierten 5-Nitro-furan-, 5-Nitro-thiophen- und 5-Nitro-pyrrolderivaten
CH484913A (de) Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
NL7514765A (nl) Tyrosine derivaten en werkwijze voor hun bereiding en toepassing.
IT971959B (it) Formulazione atta all impiego in isocianurati rigidi e relativi isocianurati rigidi
CH484912A (de) Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-Anilino-1,3-diazacyclopentens-(2)
DK345677A (da) Fremgangsmade til fremstilling af cyanoprostaglandiner samt mellemprodukt til brug ved fremgangsmaden
IL32216A0 (en) Derivatives of the 2-(lower alkyl)-3-(lower alkyl)-4-aryl-cyclohexenylcarbinols and their preparation
DK201679A (da) Cyloaliphatiske ketoaminer fremgangsmaade til deres fremstilling samt deres anvendelse
DK40480A (da) Urinstofderivater samt deres fremstilling og anvendelse
AR192570A1 (es) Procedimiento para la preparacion de derivados de benzodiacepina y derivados de quinolona utiles en dicho procedimiento
BE746442A (fr) Derives d'organo-etains et leur utilisation
DK521980A (da) Indolizinderivater samt deres fremstilling

Legal Events

Date Code Title Description
PUP Patent expired